We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVAC
2326
DELISTED
CureVac
CVAC
$44.3K ﹤0.01%
14,610
-74,490
-84% -$261K
CNVS icon
2327
Cineverse
CNVS
$58.8M
$43.1K ﹤0.01%
+31,012
New +$44.6K
ORGO icon
2328
Organogenesis Holdings
ORGO
$328M
$42.9K ﹤0.01%
15,114
-807,040
-98% -$2.74M
HUMA icon
2329
Humacyte
HUMA
$182M
$42.4K ﹤0.01%
13,631
-143,529
-91% -$483K
DMTK
2330
DELISTED
DermTech, Inc. Common Stock
DMTK
$40.3K ﹤0.01%
57,577
EFA icon
2331
iShares MSCI EAFE ETF
EFA
$76.8B
$39.9K ﹤0.01%
+500
New +$38.2K
BA icon
2332
PUT
Boeing
BA
$167B
$36.2K ﹤0.01%
+200
New +$41.1K
KNDI
2333
Kandi Technologies Group
KNDI
$64.6M
$35.6K ﹤0.01%
16,815
-34,315
-67% -$88K
CLDI icon
2334
Calidi Biotherapeutics
CLDI
$2.11M
$35.3K ﹤0.01%
+516
New +$52.7K
APPS icon
2335
Digital Turbine
APPS
$1.04B
$34.7K ﹤0.01%
13,230
-46,370
-78% -$197K
PG icon
2336
PUT
Procter & Gamble
PG
$346B
$33.2K ﹤0.01%
200
-204,200
-100% -$32M
AEON.WS
2337
CALL
DELISTED
AEON Biopharma Inc
AEON.WS
$32.3K ﹤0.01%
19,785
-8,400
-30% -$5.15K
RTB
2338
RTB Digital
RTB
$230M
$30.1K ﹤0.01%
297
PASG icon
2339
Passage Bio
PASG
$14.8M
$29.7K ﹤0.01%
+1,100
New +$26.5K
ATRA icon
2340
Atara Biotherapeutics
ATRA
$69.5M
$29.1K ﹤0.01%
1,690
-10,010
-86% -$178K
EQ icon
2341
Equillium
EQ
$156M
$27.5K ﹤0.01%
+11,897
New +$20.7K
PGSS.WS
2342
CALL
DELISTED
Pegasus Digital Mobility Acquisition Corp. Redeemable Warrants
PGSS.WS
$27K ﹤0.01%
100,000
ZCARW
2343
CALL
DELISTED
Zoomcar Holdings, Inc. Warrants
ZCARW
$21.7K ﹤0.01%
70,000
-14,968
-18% -$1.03K
CUTR
2344
DELISTED
Cutera, Inc.
CUTR
$18.3K ﹤0.01%
12,431
-143,751
-92% -$373K
SUAC.WS
2345
CALL
DELISTED
ShoulderUp Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
SUAC.WS
$17.3K ﹤0.01%
+575,100
New +$17.3K
MSPR
2346
DELISTED
MSP Recovery Inc
MSPR
$17.2K ﹤0.01%
142
-2
-1% -$374
LUXH
2347
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
$16.2K ﹤0.01%
167
-311
-65% -$74.9K
CLDI.WS
2348
CALL
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$16.1K ﹤0.01%
70,000
-2,278
-3% -$137
ROSS.WS
2349
CALL
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$14.9K ﹤0.01%
165,704
-8,881
-5% -$691
XME icon
2350
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$3.96B
$12.5K ﹤0.01%
200
-68,600
-100% -$3.92M

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.